In this respect, epigenetic upregulation of orphan nuclear receptor NR2F1 is detected in DTCs from the breast [131], and prostate cancer patients harboring lifelong dormant disease and in experimental latency models of head and neck squamous cell carcinoma (HNSCC). Here, ESRRB is linked to head and neck squamous cell carcinoma.